Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of proteins, cytokines, and other biomarkers. These kits are widely used in drug ...
News Medical on MSN5h
IgE antibodies show promise in targeting HER2 cancers resistant to other therapiesAntibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.
In this week’s edition of the biotech bi-weekly, learn more about CRAIC technologies’ 5D Spectral Surface Mapping solution, ...
Pierre Fabre SA and Redridge Bio AG have signed an exclusive R&D collaboration and license agreement to identify and develop ...
Vaccine effectiveness relies on creating a strong antibody response that can be reactivated to fight future infections. Now, ...
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with ...
VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and ...
University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...
MediLink Therapeutics Ltd. is exploring a licensing partnership to develop an antibody-drug conjugate with a global ...
NextCure (NASDAQ:NXTC – Get Free Report) is anticipated to release its earnings data before the market opens on Thursday, ...
Compass Therapeutics (NASDAQ:CMPX – Get Free Report) is anticipated to release its earnings data before the market opens on ...
MedPage Today on MSN1d
Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ARTSAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback